×

Method for producing α-1, 6-branched α-1, 4-glucans from sucrose

  • US 7,638,311 B2
  • Filed: 07/20/2007
  • Issued: 12/29/2009
  • Est. Priority Date: 10/09/1998
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for producing α

  • -1,6-branched α

    -1,4-glucans in in-vitro systems comprising(1) expressing in an in-vitro system a protein encoded by a nucleic acid molecule encoding a branching enzyme from a bacterium of the genus Neisseria selected from the group consisting of(a) a nucleic acid molecule encoding a protein which comprises the amino acid sequence depicted in SEQ ID NO. 2;

    (b) a nucleic acid molecule comprising the coding region depicted in SEQ ID NO. 1;

    (c) a nucleic acid molecule encoding a protein which comprises the amino acid sequence encoded by the insert in plasmid DSM 12425; and

    (d) a nucleic acid molecule comprising the coding region for a branching enzyme, which is contained in the insert of the plasmid DSM 12425;

    (e) a nucleic acid molecule encoding a protein the sequence of which has, a homology of at least 95% to the amino acid sequence depicted in SEQ ID NO. 2, and wherein positions 1-7 are SEQ ID NO;

    8, positions 52-57 are SEQ ID NO;

    9, positions 88-94 are SEQ ID NO;

    10, positions 100-104 are SEQ ID NO;

    11, positions 109-113 are SEQ ID NO;

    12and positions 115-119 are SEQ ID NO;

    13;

    (f) a nucleic acid molecule having more than 95% identity with SEQ ID NO;

    1, wherein said nucleic acid encodes a protein having SEQ ID NO;

    8 at positions 1-7, SEQ ID NO;

    9 at positions 52-57, SEQ ID NO;

    10 at positions 88-94, SEQ ID NO;

    11 at positions 100-104, SEQ ID NO;

    12 at positions 109-113, are SEQ ID NO;

    13 at positions 115-119, SEQ ID NO;

    14 at positions 134-138, SEQ ID NO;

    15 at positions 147-151, SEQ ID NO;

    16 at positions 162-166, SEQ ID NO;

    17 at positions 168-172, SEQ ID NO;

    18 at positions 199-203, SEQ ID NO;

    19 at positions 217-221, SEQ ID NO;

    20 at positions 225-230, SEQ ID NO;

    21 at positions 244-248, SEQ ID NO;

    22 at positions 282-287, SEQ ID NO;

    23 at positions 299-304, SEQ ID NO;

    24 at positions 312-317, SEQ ID NO;

    25 at positions 356-360, SEQ ID NO;

    26 at positions 379-383, SEQ ID NO;

    27 at positions 412-416, SEQ ID NO;

    28 at positions 439-444, SEQ ID NO;

    29 at positions 467-472, SEQ ID NO;

    30 at positions 505-509, SEQ ID NO;

    31 at positions 553-558, SEQ ID NO;

    32 at positions 686-690, SEQ ID NO;

    33 at positions 739-746 and SEQ ID NO;

    34 at positions 754-762 of SEQ ID NO;

    2; and

    (g) a nucleic acid molecule the sequence of which deviates from the sequence of the nucleic acid molecule of (f) due to the degeneracy of the genetic code;

    (2) contacting said protein with sucrose and amylosucrase;

    orand isolating said α

    -1,6-branched α

    -1,4-glucans.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×